Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS5474552 A
Publication typeGrant
Application numberUS 08/266,736
Publication date12 Dec 1995
Filing date27 Jun 1994
Priority date27 Jun 1994
Fee statusPaid
Also published asDE69533549D1, DE69533549T2, EP0767687A1, EP0767687A4, EP0767687B1, WO1996000106A1
Publication number08266736, 266736, US 5474552 A, US 5474552A, US-A-5474552, US5474552 A, US5474552A
InventorsYoram Palti
Original AssigneeCb-Carmel Biotechnology Ltd.
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Implantable drug delivery pump
US 5474552 A
Abstract
A method and apparatus for maintaining the concentration of glucose in a person, animal or tissue within a predetermined range is disclosed. An implanted sensor of living cells produces a detectable electrical signal which varies with the concentration of glucose. A controller detects the electrical signal produced by the sensor and determines if the concentration of glucose is within the predetermined range. If the glucose is too low or too high, the controller activates a pump causing either glucose or glucagon, or insulin to be delivered to the person until the glucose level is within the predetermined range. A separate pump for delivering each of the glucose and insulin may be used, or a single pump which is switchable between them may be used. The system may be adapted to maintain other constituents or conditions within a predetermined range by changing the sensor in use, and by using agents and counteragents appropriate to the condition or constituent level being monitored.
Images(2)
Previous page
Next page
Claims(17)
I claim:
1. An apparatus for regulating a condition or concentration of a constituent in a person, animal, or living tissue the constituent or condition being increasable by delivery of an agent to the person, animal or living tissue, and decreasable by delivery of a counteragent to the person, animal or living tissue;
the apparatus comprising:
a sensor implanted in the person or tissue, the sensor producing a detectable signal which varies with the concentration of the constituent or the existence of the condition in a medium surrounding the sensor;
a source of agent;
a source of counteragent;
delivery means for controllably delivering each of the agent and counteragent to the person or tissue; and
a controller for detecting the signal produced by the sensor and for determining if the concentration of the constituent or the condition is within a predetermined range, the controller causing the delivery means to selectively deliver agent or counteragent to maintain the concentration of the constituent or the condition within the predetermined range.
2. The apparatus according to claim 1 wherein the sensor is an implantable mass of living cells.
3. The apparatus according to claim 2 wherein the constituent is glucose and the implantable mass of cells is sensitive to glucose levels.
4. The apparatus according to claim 3 wherein the agent is glucose and the counteragent is insulin.
5. The apparatus according to claim 3 wherein the agent is glucagon and the counteragent is insulin.
6. The apparatus according to claim 3 wherein the delivery means comprises:
a pump for the glucose; and
a pump for the insulin.
7. The apparatus according to claim 3 wherein the delivery means comprises:
a pump; and
a coupling for switching the pump between the source of glucose and the source of insulin.
8. The apparatus according to claim 1 wherein the delivery means comprises:
a pump for the agent; and
a pump for the counteragent.
9. The apparatus according to claim 1 wherein the delivery means comprises:
a pump; and
a coupling for switching the pump between the source of agent and the source of counteragent.
10. A method for maintaining a condition or concentration of a constituent in a person, animal or other living tissue within a predetermined range, the constituent or condition being increasable by delivery of an agent to the person, animal or living tissue and decreasable by delivery of a counteragent to the person, animal or living tissue;
the method comprising:
implanting a sensor in the person or tissue, the sensor producing a detectable signal which varies with the concentration of the constituent or the existence of the condition in a medium surrounding the sensor;
providing a source of agent;
providing a source of counteragent;
detecting the signal produced by the sensor and determining if the concentration of the constituent or the condition is within the predetermined range; and
selectively and controllably delivering the agent or counteragent to the person, animal or tissue to maintain the concentration of the constituent or the condition within the predetermined range.
11. The method according to claim 10 wherein the sensor is an implantable mass of living cells.
12. The method according to claim 11 wherein the constituent is glucose and the implantable mass of cells is sensitive to glucose levels.
13. The method according to claim 12 wherein the agent is glucose and the counteragent is insulin.
14. The method according to claim 12 wherein the agent is glucagon and the counteragent is insulin.
15. An apparatus for regulating glucose levels in a person, the apparatus comprising:
a sensor implanted in the person, the sensor comprising a mass of living cells which generate a detectable electrical signal which varies with the concentration of glucose in the person;
a source of glucose or glucagon;
a source of insulin;
at least one pump for controllably delivering the glucose or glucagon and insulin to the person; and
a controller for detecting the electrical signal produced by the sensor and for determining if the glucose concentration in the person is within a predetermined range, the controller causing the pump to selectively deliver glucose or glucagon, or insulin to the person until the concentration of glucose in the person is within the predetermined range.
16. The apparatus according to claim 15 which comprises:
a pump for the glucose or glucagon; and
a pump for the insulin.
17. The apparatus according to claim 15 which:
a single pump for pumping the glucose or glucagon, and insulin; and
a coupling for switching the pump between the source of glucose or glucagon and the source of insulin.
Description
BACKGROUND OF THE INVENTION

1. Field of the Invention

The present invention relates to a method and apparatus for continuously detecting the level of glucose in a person, and for automatically delivering glucose or glucagon, and insulin to the person to maintain the glucose level in a desired range. The invention also relates to a method and apparatus for regulating other conditions or constituent levels in a person, tissue, or animal by continuously sensing the condition or constituent levels and delivering an agent and counteragent for maintaining the condition or constituent levels in a desired range.

2. Description of the Related Art

One of the more advanced methods of drug delivery is one in which the amount of a drug delivered is controlled by a sensor. The sensor reads, for example, the concentration of a constituent in the blood or tissue, or the magnitude of the results of a previous drug delivery, and alters the quantity or rate of delivery of a drug for altering the detected constituent concentration. For example, in a system for insulin delivery, the sensor can read the blood glucose level and vary the insulin delivery amount or rate accordingly.

At present there are very few sensors available which can function in this manner. One such sensor is disclosed in commonly owned U.S. Pat. Nos. 5,101,814 and 5,190,041, and U.S. patent application Ser. No. 08/077,893, the contents of which are incorporated herein by reference. This sensor comprises a mass of living cells which are sensitive to a particular constituent, preferably glucose. The cells are encapsulated in a biocompatible semi-permeable membrane and generate a detectable electrical signal which varies with the concentration of the constituent in the medium that surrounds the cells or capsule.

Most existing feedback controlled drug delivery systems suffer from the inability to lower the drug level, or its efficacy, once delivered. Thus, any overdose cannot be counteracted and one has to wait until natural metabolism and excretion lower the level of the agent administered.

There are however cases where a counteragent is available. For example, in the case of insulin hormone delivery, if an overdose is sensed by the sensor in the form of a too low glucose level, the situation can be corrected by delivery of glucose, or the hormone glucagon, etc.

It is therefore an object of the present invention to improve sensor controlled delivery systems by providing the capability to automatically deliver either a chemical agent or counteragent based on continuous sensor readings to maintain the level of a constituent or condition, for example blood pressure, within a desired range.

SUMMARY OF THE INVENTION

The present invention is a method and apparatus for maintaining the concentration of a constituent in a person, tissue, animal, etc. within a predetermined range or to follow specified programmed changes. Although the constituent preferably glucose, it may be any constituent or condition which can be regulated by delivery of an agent to increase or decrease the constituent level or condition, and a counteragent to decrease or increase the constituent level or condition.

A sensor, preferably of the type which produces a detectable electrical signal which varies with the concentration of the constituent or the existence of the condition is implanted in the person. A controller detects the electrical signal produced by the sensor and determines if the concentration of the constituent or the condition is within a predetermined range at a given time. If the level or condition is too low or too high, the controller activates a pump causing either agent or counteragent to be delivered to the person until the constituent or condition is within the predetermined range, or, if the body response is slower than the delivery, until the predicted constituent or condition level is within a required range.

In a preferred embodiment, the sensor is an implantable mass of living cells which is sensitive to glucose levels and the delivered drugs are glucose or glucagon and insulin. A separate pump for delivering each of the agent and counteragent may be used, or a single pump which is switchable between the agent and counteragent may be used.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 shows a block diagram of the drug delivery system of the present invention.

FIG. 2 shows a block diagram of an alternative embodiment of the drug delivery system of the present invention.

FIG. 3 shows a schematic diagram of another alternative embodiment of the drug delivery system of the present invention.

FIG. 4 shows sample electrical signals generated by an implanted cell mass.

DESCRIPTION OF THE PREFERRED EMBODIMENT

The present invention is a drug delivery system in which a condition or constituent level in a person, tissue or animal is continuously monitored, and maintained within a predetermined range. As shown in FIG. 1, the invention includes a sensor 2, a controller or control system 4, an agent delivery system 6, and a counteragent delivery system 8. In an alternative embodiment, as shown in FIG. 2, a separate pump 10 is provided for delivering each of the agent and counteragent. In the embodiment shown in FIG. 1, the pump is incorporated in the agent and counteragent delivery systems 6 and 8.

Sensor 2 is implanted in the body tissue or fluids of a person and generates an electrical or other detectable signal in response to the presence of constituents to which the sensor is sensitive, or other conditions, i.e. temperature, pressure, etc. For example, such a sensor might be of the type disclosed in commonly owned U.S. Pat. Nos. 5,101,814 and 5,190,041, and U.S. patent application Ser. No. 08/077,893. In these sensors, living cells which generate a varying electrical signal in the presence of constituents to which the cells are sensitive are encapsulated in a biocompatible semi-permeable membrane, and the electrical activity of the living cells is measured. The sensors may be sensitive to glucose levels, for example, and generate an electrical signal which varies with the concentration of glucose in the medium surrounding the sensor 2. The sensors may also generate other non-electrical signals, i.e. optical, chemical, etc. provided that the signals are detectable. Of course, it is foreseen that any type of appropriate sensor, whether implanted or not, may be used in the present system.

Controller 4 receives the electrical output of sensor 2, and determines whether the level of the constituent or condition is too high or too low, and thus requires administration of an agent or counteragent to raise or lower the level. The controller then regulates the delivery of agent and counteragent to maintain the constituent level or condition to which the sensor is sensitive within a predetermined range, or to follow specified programmed changes. The controller 4, pump 10 and the delivery systems 6 and 8 are preferably implanted within the body, with the sensor 2 connected to the controller using conventional leads, with the agents and counteragents being delivered to the person by any means known in the art. In the alternative, any combination of the controller 4, pump 10 delivery systems 6 and 8, as well as a supply of the agent and counteragent, may be located outside the body with the sensor connected to the controller using conventional electrodes or electrical pickups, with agent and counteragent being delivered to the person by tubing of the type known in the art. If appropriate, sensor 2 may also be located outside of the body.

Although the preferred embodiment will be described in detail with respect to the delivery of a soluble drug, the agent(s) to be delivered can be any type of drug, hormone, pH buffering solution, living cells or other agents in suspension, or any other biologically active material, etc. depending upon the type of sensor 2 in use and the constituent or condition being monitored.

The drug delivery system must be able to deliver a controlled volume or a controlled rate of the agent or counteragent into the appropriate body fluid, cavity or tissue, i.e., blood, peritoneal cavity, subcutaneous tissue, etc. In a preferred embodiment, as shown in FIG. 2, the delivery of the drug is done by an electrically controlled pump 10. The pump 10 may be of any conventionally known type, including a piston or piston equivalent (fluid or gas) driven pump, a peristaltic pump, centrifugal pump, etc. In the alternative, the drug delivery may be carried out by controlled diffusion, by an electric current that carries a charged agent, by charged molecules or particles, by magnetic particles, etc.

As shown in FIG. 3, the present invention shall now be described with respect to an implanted insulin-glucose or insulin-glucagon delivery system. The glucose sensors 2, are of the type disclosed in the aforementioned U.S. Pat. Nos. 5,101,814 and 5,190,041, and U.S. patent application Ser. No. 08/077,893. Each sensor comprises a mass of living cells 14 which are sensitive to glucose levels and which generate an electrical signal which varies with the concentration of glucose in the medium surrounding the cells, as shown in simplified form in FIG. 4. The mass of cells 14 may be contained in a capsule of the type disclosed in the commonly owned co-pending U.S. Patent application entitled "IMPLANTABLE CAPSULE FOR ENHANCING CELL ELECTRIC SIGNALS", filed concurrently herewith

The sensors 2 are implanted in a body cavity where the glucose concentration is representative of the overall blood glucose concentration in the person. The sensors 2 continuously sense the glucose concentration by means of electrodes 16 and transmit this information to the control system 4 by means of leads 17. Electrodes 16 may be of any type known to those skilled in the art.

The control system 4 includes an amplifier 18 which receives and amplifies the signals from the sensors 2. The controller 4 processes the inputs for determining the glucose levels in the person. The controller may further process the sensor readings to compensate for concentration reduction and delays due to diffusion, etc. Using the glucose readings and a drug activation algorithm 20, the controller 4 determines whether drug delivery is appropriate and, if so, generates control signals to cause the delivery of glucose via glucose pump 22 or the delivery of insulin via insulin pump 24.

The controller 4 can be of any type for performing the functions set forth herein. For example, controller 4 may be a modified On-Off type or a Proportional Control type. In the first case, if the controller 4 determines that the glucose concentration exceeds a specified criterion at the given time, insulin pump 24 is activated at predetermined rates for specified durations so as to appropriately lower the blood glucose levels. The pumping mechanism itself may include either a dedicated pump for each agent, as shown in FIG. 3, or a single pump which can pump more than one agent, as shown in FIG. 2. In the single pump embodiment, the controller 4 activates the pump 10 and couples it with the appropriate delivery system, i.e., the glucose system or the insulin system. The coupling 12 may be a mechanical gear that switches the pump cylinder, for example, or a valve that allows the correct agent to flow once the system is pressurized, or any other conventionally known coupling. When the sensors 2 and controller 4 detect a normal glucose level, the pump 10 is stopped or switched to a basal level or another predetermined level which indicates that the level will approach the normal range without any further intervention.

When the sensors 2 and controller 4 detect a glucose level below a certain level, the glucose delivery system 22 is activated. This may be done either by activating the appropriate pump, or by switching the single pump to deliver glucose. If desired, the control system 4 can activate a glucagon delivery system. Glucagon is a hormone that counteracts many of the effects of insulin and increases blood glucose levels.

If the controller 4 is of the proportional type, the control algorithm causes the delivery system to output an amount or delivery rate of the agents or counteragents in proportion to the detected level of the constituent being detected.

If desired, the present system can be modified so that more than two related chemicals may be delivered. For example, the system may be a three agent delivery system, wherein the controller can activate and regulate the delivery of insulin, glucose, and glucagon, each at the appropriate rate and amount.

Although the present invention has been described in detail with respect to certain embodiments and examples, variations and modifications exist which are within the scope of the present invention as defined in the following claims.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US4055175 *7 May 197625 Oct 1977Miles Laboratories, Inc.Blood glucose control apparatus
US4282872 *13 Dec 197811 Aug 1981Siemens AktiengesellschaftDevice for the pre-programmable infusion of liquids
US4731051 *15 Feb 198315 Mar 1988The Johns Hopkins UniversityProgrammable control means for providing safe and controlled medication infusion
US4822336 *4 Mar 198818 Apr 1989Ditraglia JohnBlood glucose level sensing
US4925444 *7 Aug 198715 May 1990Baxter Travenol Laboratories, Inc.Closed multi-fluid delivery system and method
US5101814 *11 Aug 19897 Apr 1992Palti Yoram ProfSystem for monitoring and controlling blood glucose
US5104374 *16 Jan 199014 Apr 1992Bishko Jay RElectronic fluid flow rate controller for controlling the infusion of intravenous drugs into a patient
US5190041 *27 Dec 19912 Mar 1993Palti Yoram ProfSystem for monitoring and controlling blood glucose
US5190522 *11 Apr 19912 Mar 1993Institute Of Biocybernetics And Biomedical Engineering P.A.S.Device for monitoring the operation of a delivery system and the method of use thereof
US5298021 *24 Sep 199229 Mar 1994Sherer David JACLS infusion pump system
Non-Patent Citations
Reference
1Hildebrandt, G., et al., "Results of continuous long-term intravenous application of octreotide via an implantable pump system in acromegaly resistant to operative and X-ray therapy." Acta Neurochir (Wein) 117 (1992): 160-165.
2 *Hildebrandt, G., et al., Results of continuous long term intravenous application of octreotide via an implantable pump system in acromegaly resistant to operative and X ray therapy. Acta Neurochir ( Wein ) 117 (1992): 160 165.
3Jeandidier, N., et al., "Comparison of intraperitoneal insulin infusion (using implantable pump) and subcutaneous insulin administration: preliminary results of a crossover study." Transplant Proc 24 (1992). 948-949.
4 *Jeandidier, N., et al., Comparison of intraperitoneal insulin infusion (using implantable pump) and subcutaneous insulin administration: preliminary results of a crossover study. Transplant Proc 24 (1992). 948 949.
5 *Meize Grochowski, A. R. Health locus of control and glycosylated haemoglobin concentration of implantable insulin pump recipients in Austria. J Adv Nurs 15 (1990): 804 807.
6Meize-Grochowski, A. R. "Health locus of control and glycosylated haemoglobin concentration of implantable insulin pump recipients in Austria." J Adv Nurs 15 (1990): 804-807.
7Ranade, V. V. "Drug delivery systems. 4. Implants in drug delivery. [Review]." J. Clin Pharmacol 30 (1990): 871-889.
8 *Ranade, V. V. Drug delivery systems. 4. Implants in drug delivery. Review . J. Clin Pharmacol 30 (1990): 871 889.
9Saudek, C. D. "Implantable insulin infusion pumps." The Endocrinologist 3 (1993): 15-20.
10Saudek, C. D. "Implantable insulin pumps: a current look." Diabetes Research & Clinical Practive (1990): 109-114.
11 *Saudek, C. D. Implantable insulin infusion pumps. The Endocrinologist 3 (1993): 15 20.
12 *Saudek, C. D. Implantable insulin pumps: a current look. Diabetes Research & Clinical Practive (1990): 109 114.
13Saudek, C. D., "Future developments in insulin delivery systems." Diabetes Care 16 (1993): 122-132.
14Saudek, C. D., et al. "The Dept. of Veterans Affairs implanted insulin pump study." Diabetes Care (1992): 567-570.
15 *Saudek, C. D., et al. The Dept. of Veterans Affairs implanted insulin pump study. Diabetes Care (1992): 567 570.
16Saudek, C. D., et al., "The Programmable implantable medication system (PIMS): design features and pre-clinical trials. [Review]." Horm Metab Res 22 (1990): 201-206.
17 *Saudek, C. D., et al., The Programmable implantable medication system (PIMS): design features and pre clinical trials. Review . Horm Metab Res 22 (1990): 201 206.
18 *Saudek, C. D., Future developments in insulin delivery systems. Diabetes Care 16 (1993): 122 132.
19Selam, J. L. "Implantable insulin pumps: a major piece of computerized diabetic therapy. [Review]." Horm Metab Res Suppl 24 (1990): 144-154.
20Selam, J. L. and G. Slama. "[Insulin administration systems; possibilities and difficulties]. [Review][French]." Presse Med 21 (1992): 1575-1580.
21 *Selam, J. L. and G. Slama. Insulin administration systems; possibilities and difficulties . Review French . Presse Med 21 (1992): 1575 1580.
22 *Selam, J. L. Implantable insulin pumps: a major piece of computerized diabetic therapy. Review . Horm Metab Res Suppl 24 (1990): 144 154.
23Selam, J. L., et al., "Clinical trial of programmable implantable insulin pump for type 1 diabetes." Diabetes Care 15 (1992): 877-885.
24 *Selam, J. L., et al., Clinical trial of programmable implantable insulin pump for type 1 diabetes. Diabetes Care 15 (1992): 877 885.
25Waxman, K., et al. "Implantable programmable insulin pumps for the treatment of diabetes." Arch Surg. 127 (1992): 1032-6; discussion 1036-7.
26 *Waxman, K., et al. Implantable programmable insulin pumps for the treatment of diabetes. Arch Surg. 127 (1992): 1032 6; discussion 1036 7.
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US5846188 *17 Jan 19978 Dec 1998Palti; YoramSensor utilizing living muscle cells
US5995860 *6 Jul 199530 Nov 1999Thomas Jefferson UniversityImplantable sensor and system for measurement and control of blood constituent levels
US6049727 *3 Apr 199811 Apr 2000Animas CorporationImplantable sensor and system for in vivo measurement and control of fluid constituent levels
US6122536 *8 Jul 199619 Sep 2000Animas CorporationImplantable sensor and system for measurement and control of blood constituent levels
US6558345 *17 Apr 20006 May 2003Medtronic, Inc.System for delivering insulin
US6673596 *2 Dec 19996 Jan 2004Ut-Battelle, LlcIn vivo biosensor apparatus and method of use
US6740072 *26 Dec 200125 May 2004Medtronic Minimed, Inc.System and method for providing closed loop infusion formulation delivery
US6890304 *2 Jun 200010 May 2005Seiko Epson CorporationDevice for diagnosing physiological state and device for controlling the same
US690254422 Jan 20037 Jun 2005Codman & Shurtleff, Inc.Troubleshooting accelerator system for implantable drug delivery pumps
US697074117 Sep 200229 Nov 2005Advanced Bionics CorporationMonitoring, preventing, and treating rejection of transplanted organs
US698675523 Aug 200117 Jan 2006Disetronic Licensing AgSensor system including port body
US708978331 May 200515 Aug 2006Codman & Shurtleff, Inc.Trouble shooting accelerator system for implantable drug delivery pumps
US71086806 Mar 200219 Sep 2006Codman & Shurtleff, Inc.Closed-loop drug delivery system
US727605730 Apr 20042 Oct 2007Medtronic, Inc.Method, system and device for treating disorders of the pelvic floor by drug delivery to the pudendal and sacral nerves
US73083031 Nov 200211 Dec 2007Advanced Bionics CorporationThrombolysis and chronic anticoagulation therapy
US731485923 Dec 20031 Jan 2008Diobex, Inc.Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US732806826 Nov 20035 Feb 2008Medtronic, Inc.Method, system and device for treating disorders of the pelvic floor by means of electrical stimulation of the pudendal and associated nerves, and the optional delivery of drugs in association therewith
US7328069 *30 Apr 20045 Feb 2008Medtronic, Inc.Method, system and device for treating disorders of the pelvic floor by electrical stimulation of and the delivery of drugs to the left and right pudendal nerves
US7368085 *4 Dec 20036 May 2008Honeywell International Inc.Analyte detector
US736989430 Apr 20046 May 2008Medtronic, Inc.Method, system and device for treating disorders of the pelvic floor by electrical stimulation of the sacral and/or pudendal nerves
US742728030 Apr 200423 Sep 2008Medtronic, Inc.Method, system and device for treating disorders of the pelvic floor by delivering drugs to various nerves or tissues
US7509156 *18 May 200524 Mar 2009Clarian Health Partners, Inc.System for managing glucose levels in patients with diabetes or hyperglycemia
US759180126 Feb 200422 Sep 2009Dexcom, Inc.Integrated delivery device for continuous glucose sensor
US763789217 Nov 200629 Dec 2009Palyon Medical (Bvi) LimitedVariable flow infusion pump system
US764223221 Dec 20075 Jan 2010Diobex, Inc.Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US765495610 Mar 20052 Feb 2010Dexcom, Inc.Transcutaneous analyte sensor
US765561828 Jun 20052 Feb 2010Diobex, Inc.Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US766214023 Dec 200316 Feb 2010Medtronic, Inc.Method of delivering drug to brain via spinal cord
US767876229 Oct 200716 Mar 2010Diobex, Inc.Methods for reducing the risk of hypoglycemia
US767876329 Oct 200716 Mar 2010Diobex, Inc.Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US768302729 Oct 200723 Mar 2010Diobex, Inc.Methods relating to hypoglycemic unawareness
US771140222 Dec 20044 May 2010Dexcom, Inc.Device and method for determining analyte levels
US77158933 Dec 200411 May 2010Dexcom, Inc.Calibration techniques for a continuous analyte sensor
US776113027 Mar 200720 Jul 2010Dexcom, Inc.Dual electrode system for a continuous analyte sensor
US77713521 May 200810 Aug 2010Dexcom, Inc.Low oxygen in vivo analyte sensor
US77786801 Aug 200317 Aug 2010Dexcom, Inc.System and methods for processing analyte sensor data
US778333310 Mar 200524 Aug 2010Dexcom, Inc.Transcutaneous medical device with variable stiffness
US779702814 Apr 200814 Sep 2010Dexcom, Inc.System and methods for processing analyte sensor data
US781124626 Oct 200612 Oct 2010Inreda Diabetic B.V.Device for automatic regulation of the concentration of glucose in the blood of a diabetes patient
US782698118 Jan 20052 Nov 2010Dexcom, Inc.System and methods for processing analyte sensor data
US783128728 Apr 20089 Nov 2010Dexcom, Inc.Dual electrode system for a continuous analyte sensor
US785064123 Jun 200914 Dec 2010Medtronic Minimed, Inc.Safety limits for closed-loop infusion pump control
US785776022 Feb 200628 Dec 2010Dexcom, Inc.Analyte sensor
US78605447 Mar 200728 Dec 2010Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US78698536 Aug 201011 Jan 2011Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US788569710 Mar 20058 Feb 2011Dexcom, Inc.Transcutaneous analyte sensor
US78856996 Aug 20108 Feb 2011Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US78968093 Nov 20081 Mar 2011Dexcom, Inc.Dual electrode system for a continuous analyte sensor
US789951117 Jan 20061 Mar 2011Dexcom, Inc.Low oxygen in vivo analyte sensor
US79013541 May 20088 Mar 2011Dexcom, Inc.Low oxygen in vivo analyte sensor
US79041627 Oct 20058 Mar 2011Boston Scientific Neuromodulation CorporationMonitoring, preventing, and treating rejection of transplanted organs
US790583321 Jun 200515 Mar 2011Dexcom, Inc.Transcutaneous analyte sensor
US79144503 May 201029 Mar 2011Dexcom, Inc.System and methods for processing analyte sensor data
US791718616 Nov 200929 Mar 2011Dexcom, Inc.Calibration techniques for a continuous analyte sensor
US79209069 Mar 20065 Apr 2011Dexcom, Inc.System and methods for processing analyte sensor data for sensor calibration
US79209077 Jun 20075 Apr 2011Abbott Diabetes Care Inc.Analyte monitoring system and method
US792532123 Mar 201012 Apr 2011Dexcom, Inc.System and methods for processing analyte sensor data
US792727429 Jul 200819 Apr 2011Dexcom, Inc.Integrated receiver for continuous analyte sensor
US792786929 Nov 200619 Apr 2011Spencer Z RoseroSystem and method for supporting a biological chip device
US793363923 Mar 201026 Apr 2011Dexcom, Inc.System and methods for processing analyte sensor data
US793505714 Jan 20093 May 2011Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US793507928 Jun 20063 May 2011Codman & Shurtleff, Inc.Troubleshooting accelerator system for implantable drug delivery pumps
US793879629 Mar 200710 May 2011Baxter International Inc.Method and system for controlled infusion of therapeutic substances
US794698410 Mar 200524 May 2011Dexcom, Inc.Transcutaneous analyte sensor
US794938111 Apr 200824 May 2011Dexcom, Inc.Transcutaneous analyte sensor
US795526123 Mar 20107 Jun 2011Dexcom, Inc.System and methods for processing analyte sensor data
US795956923 Mar 201014 Jun 2011Dexcom, Inc.System and methods for processing analyte sensor data
US796394629 Mar 200721 Jun 2011Baxter International Inc.Method and system for controlled infusion of therapeutic substances
US79764926 Aug 200912 Jul 2011Dexcom, Inc.Integrated delivery device for continuous glucose sensor
US797910426 May 201012 Jul 2011Dexcom, Inc.System and methods for processing analyte sensor data
US798698623 Mar 201026 Jul 2011Dexcom, Inc.System and methods for processing analyte sensor data
US799807114 Oct 200916 Aug 2011Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US80009019 Aug 201016 Aug 2011Dexcom, Inc.Transcutaneous analyte sensor
US800552424 Mar 201023 Aug 2011Dexcom, Inc.Signal processing for continuous analyte sensor
US800552514 Oct 200923 Aug 2011Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US801017422 Aug 200330 Aug 2011Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US802563418 Sep 200627 Sep 2011Baxter International Inc.Method and system for controlled infusion of therapeutic substances
US804328122 Jun 200425 Oct 2011Medtronic, Inc.Catheters incorporating valves and permeable membranes
US805260120 Aug 20088 Nov 2011Dexcom, Inc.System and methods for processing analyte sensor data
US80601731 Aug 200315 Nov 2011Dexcom, Inc.System and methods for processing analyte sensor data
US807351914 Oct 20096 Dec 2011Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US807352025 May 20106 Dec 2011Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US810526819 Oct 201031 Jan 2012Medtronic Minimed, Inc.Safety limits for closed-loop infusion pump control
US811405510 May 200514 Feb 2012Palyon Medical (Bvi) LimitedImplantable pump with infinitely variable resistor
US812856214 Oct 20096 Mar 2012Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US813317822 Feb 200613 Mar 2012Dexcom, Inc.Analyte sensor
US813733423 Dec 200320 Mar 2012Medtronic, Inc.Reduction of inflammatory mass with spinal catheters
US815048814 Oct 20093 Apr 2012Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US815278920 May 200410 Apr 2012Medtronic Minimed, Inc.System and method for providing closed loop infusion formulation delivery
US816066911 Apr 200717 Apr 2012Dexcom, Inc.Transcutaneous analyte sensor
US81606711 Sep 201017 Apr 2012Dexcom, Inc.Calibration techniques for a continuous analyte sensor
US816282930 Mar 200924 Apr 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US816780125 Mar 20101 May 2012Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US817080310 Mar 20051 May 2012Dexcom, Inc.Transcutaneous analyte sensor
US81756739 Nov 20098 May 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US817771621 Dec 200915 May 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US817775019 Nov 200915 May 2012Palyon Medical (Bvi) LimitedVariable flow infusion pump system
US818244529 Mar 200722 May 2012Baxter International Inc.Method and system for controlled infusion of therapeutic substances
US81952659 Feb 20115 Jun 2012Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US820629716 Dec 200926 Jun 2012Dexcom, Inc.System and methods for processing analyte sensor data
US821106010 May 20053 Jul 2012Palyon Medical (Bvi) LimitedReduced size implantable pump
US821613923 Sep 200910 Jul 2012Dexcom, Inc.Signal processing for continuous analyte sensor
US821617723 Dec 200310 Jul 2012Medtronic, Inc.Implantable drug delivery systems and methods
US822441310 Oct 200817 Jul 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US822655518 Mar 200924 Jul 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US822655728 Dec 200924 Jul 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US822655827 Sep 201024 Jul 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US822953426 Oct 200724 Jul 2012Dexcom, Inc.Transcutaneous analyte sensor
US822953520 Feb 200924 Jul 2012Dexcom, Inc.Systems and methods for blood glucose monitoring and alert delivery
US822953627 May 201024 Jul 2012Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US82315311 Jun 200631 Jul 2012Dexcom, Inc.Analyte sensor
US823153230 Apr 200731 Jul 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US823395812 Oct 200931 Jul 2012Dexcom, Inc.Signal processing for continuous analyte sensor
US82339591 Sep 200631 Jul 2012Dexcom, Inc.Systems and methods for processing analyte sensor data
US823412830 Dec 200331 Jul 2012Baxter International, Inc.System and method for verifying medical device operational parameters
US823589621 Dec 20097 Aug 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US824660222 Jun 200421 Aug 2012Medtronic, Inc.Catheters with tracking elements and permeable membranes
US82496841 Sep 201021 Aug 2012Dexcom, Inc.Calibration techniques for a continuous analyte sensor
US825190615 Apr 200928 Aug 2012Dexcom, Inc.Signal processing for continuous analyte sensor
US825503117 Mar 200928 Aug 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US825725916 Oct 20084 Sep 2012Dexcom, Inc.Signal processing for continuous analyte sensor
US82603929 Jun 20084 Sep 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US826039313 Jun 20074 Sep 2012Dexcom, Inc.Systems and methods for replacing signal data artifacts in a glucose sensor data stream
US826572512 Oct 200911 Sep 2012Dexcom, Inc.Signal processing for continuous analyte sensor
US82657269 Nov 200911 Sep 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US827302213 Feb 200925 Sep 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US827543723 Mar 200725 Sep 2012Dexcom, Inc.Transcutaneous analyte sensor
US82754399 Nov 200925 Sep 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US828047523 Feb 20092 Oct 2012Dexcom, Inc.Transcutaneous analyte sensor
US82825498 Dec 20049 Oct 2012Dexcom, Inc.Signal processing for continuous analyte sensor
US828255029 Jul 20089 Oct 2012Dexcom, Inc.Integrated receiver for continuous analyte sensor
US828535423 Mar 20109 Oct 2012Dexcom, Inc.System and methods for processing analyte sensor data
US82874537 Nov 200816 Oct 2012Dexcom, Inc.Analyte sensor
US828745427 Sep 201016 Oct 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US829055924 Oct 200816 Oct 2012Dexcom, Inc.Systems and methods for processing sensor data
US829056018 Nov 200816 Oct 2012Dexcom, Inc.Transcutaneous analyte sensor
US829056123 Sep 200916 Oct 2012Dexcom, Inc.Signal processing for continuous analyte sensor
US82905623 May 201016 Oct 2012Dexcom, Inc.System and methods for processing analyte sensor data
US829281027 Jan 201123 Oct 2012Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US83065989 Nov 20096 Nov 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US831174926 May 201113 Nov 2012Dexcom, Inc.Transcutaneous analyte sensor
US83134341 Mar 200720 Nov 2012Dexcom, Inc.Analyte sensor inserter system
US832114929 Jun 201127 Nov 2012Dexcom, Inc.Transcutaneous analyte sensor
US833200823 Mar 201011 Dec 2012Dexcom, Inc.System and methods for processing analyte sensor data
US834633618 Mar 20091 Jan 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US834633730 Jun 20091 Jan 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US834633827 Jan 20111 Jan 2013Dexcom, Inc.System and methods for replacing signal artifacts in a glucose sensor data stream
US835382921 Dec 200915 Jan 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US835709121 Dec 200922 Jan 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US836661430 Mar 20095 Feb 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US836991924 Oct 20085 Feb 2013Dexcom, Inc.Systems and methods for processing sensor data
US837200521 Dec 200912 Feb 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US837466716 Oct 200812 Feb 2013Dexcom, Inc.Signal processing for continuous analyte sensor
US838027311 Apr 200919 Feb 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US83860047 Sep 201126 Feb 2013Dexcom, Inc.Calibration techniques for a continuous analyte sensor
US839194517 Mar 20095 Mar 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US83940211 Oct 200712 Mar 2013Dexcom, Inc.System and methods for processing analyte sensor data
US84091317 Mar 20072 Apr 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US84123019 Feb 20112 Apr 2013Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US841731224 Oct 20089 Apr 2013Dexcom, Inc.Systems and methods for processing sensor data
US842311324 Oct 200816 Apr 2013Dexcom, Inc.Systems and methods for processing sensor data
US84231141 Oct 200716 Apr 2013Dexcom, Inc.Dual electrode system for a continuous analyte sensor
US842867816 May 201223 Apr 2013Dexcom, Inc.Calibration techniques for a continuous analyte sensor
US842867926 Mar 201023 Apr 2013Dexcom, Inc.System and methods for processing analyte sensor data
US843517927 Jan 20117 May 2013Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US844261021 Aug 200814 May 2013Dexcom, Inc.System and methods for processing analyte sensor data
US845236814 Jan 200928 May 2013Dexcom, Inc.Transcutaneous analyte sensor
US84577085 Dec 20084 Jun 2013Dexcom, Inc.Transcutaneous analyte sensor
US846023111 Jul 201111 Jun 2013Dexcom, Inc.Integrated delivery device for continuous glucose sensor
US846335014 May 201011 Jun 2013Dexcom, Inc.Transcutaneous analyte sensor
US846542530 Jun 200918 Jun 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US846787528 Mar 200718 Jun 2013Medtronic, Inc.Stimulation of dorsal genital nerves to treat urologic dysfunctions
US846988623 Sep 200925 Jun 2013Dexcom, Inc.Signal processing for continuous analyte sensor
US847302131 Jul 200925 Jun 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US847537317 Jul 20082 Jul 2013Dexcom, Inc.Transcutaneous analyte sensor
US848058019 Apr 20079 Jul 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US848379111 Apr 20089 Jul 2013Dexcom, Inc.Transcutaneous analyte sensor
US848379329 Oct 20109 Jul 2013Dexcom, Inc.Dual electrode system for a continuous analyte sensor
US849147427 Jan 201123 Jul 2013Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US850987128 Oct 200813 Aug 2013Dexcom, Inc.Sensor head for use with implantable devices
US851551610 Mar 200520 Aug 2013Dexcom, Inc.Transcutaneous analyte sensor
US851551926 Feb 200920 Aug 2013Dexcom, Inc.Transcutaneous analyte sensor
US854543511 Mar 20051 Oct 2013Baxter International, Inc.Method and apparatus for providing medical treatment therapy based on calculated demand
US854855114 May 20101 Oct 2013Dexcom, Inc.Transcutaneous analyte sensor
US854855322 Jun 20121 Oct 2013Dexcom, Inc.System and methods for processing analyte sensor data
US856003726 Mar 201015 Oct 2013Dexcom, Inc.System and methods for processing analyte sensor data for sensor calibration
US856003917 Sep 200915 Oct 2013Dexcom, Inc.Particle-containing membrane and particulate electrode for analyte sensors
US85625585 Jun 200822 Oct 2013Dexcom, Inc.Integrated medicament delivery device for use with continuous analyte sensor
US85658487 May 200922 Oct 2013Dexcom, Inc.Transcutaneous analyte sensor
US856584914 May 201022 Oct 2013Dexcom, Inc.Transcutaneous analyte sensor
US856836028 Dec 201129 Oct 2013Palyon Medical (Bvi) LimitedProgrammable implantable pump design
US857162514 May 201029 Oct 2013Dexcom, Inc.Transcutaneous analyte sensor
US85798167 Jan 201012 Nov 2013Dexcom, Inc.System and methods for processing analyte sensor data for sensor calibration
US858888216 Dec 200919 Nov 2013Dexcom, Inc.System and methods for processing analyte sensor data
US859145520 Feb 200926 Nov 2013Dexcom, Inc.Systems and methods for customizing delivery of sensor data
US85914787 Jun 201226 Nov 2013Palyon Medical (Bvi) LimitedReduced size implantable pump
US85971893 Mar 20093 Dec 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US86119787 Jan 201017 Dec 2013Dexcom, Inc.System and methods for processing analyte sensor data for sensor calibration
US861215916 Feb 200417 Dec 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US861528222 Feb 200624 Dec 2013Dexcom, Inc.Analyte sensor
US861707121 Jun 200731 Dec 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US862290511 Dec 20097 Jan 2014Dexcom, Inc.System and methods for processing analyte sensor data
US862290621 Dec 20097 Jan 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US864161921 Dec 20094 Feb 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US86498413 Apr 200711 Feb 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US865204320 Jul 201218 Feb 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US865774516 Oct 200825 Feb 2014Dexcom, Inc.Signal processing for continuous analyte sensor
US86577475 Apr 201125 Feb 2014Dexcom, Inc.Systems and methods for processing analyte sensor data
US866062717 Mar 200925 Feb 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US866310929 Mar 20104 Mar 2014Dexcom, Inc.Transcutaneous analyte sensor
US866646916 Nov 20074 Mar 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US86686453 Jan 200311 Mar 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US867081530 Apr 200711 Mar 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US867284427 Feb 200418 Mar 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US867284525 Mar 201018 Mar 2014Dexcom, Inc.Systems and methods for processing analyte sensor data
US867628711 Dec 200918 Mar 2014Dexcom, Inc.System and methods for processing analyte sensor data
US868818830 Jun 20091 Apr 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US869077511 Apr 20088 Apr 2014Dexcom, Inc.Transcutaneous analyte sensor
US87001178 Dec 200915 Apr 2014Dexcom, Inc.System and methods for processing analyte sensor data
US872154522 Mar 201013 May 2014Dexcom, Inc.Transcutaneous analyte sensor
US872158530 Mar 201213 May 2014Dex Com, Inc.Integrated delivery device for continuous glucose sensor
US873163022 Mar 201020 May 2014Dexcom, Inc.Transcutaneous analyte sensor
US873434630 Apr 200727 May 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US873434817 Mar 200927 May 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US87381093 Mar 200927 May 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US87445453 Mar 20093 Jun 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US874731523 Sep 200910 Jun 2014Dexcom. Inc.Signal processing for continuous analyte sensor
US87509552 Nov 200910 Jun 2014Dexcom, Inc.Analyte sensor
US876185627 Apr 201224 Jun 2014Dexcom, Inc.System and methods for processing analyte sensor data
US877118731 May 20118 Jul 2014Dexcom, Inc.System and methods for processing analyte sensor data
US877488724 Mar 20078 Jul 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US877488820 Jan 20108 Jul 2014Dexcom, Inc.System and methods for processing analyte sensor data
US877519630 Dec 20038 Jul 2014Baxter International Inc.System and method for notification and escalation of medical data
US87778534 Apr 201215 Jul 2014Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8777896 *19 Jan 201115 Jul 2014Medtronic Minimed, Inc.System and method for providing closed loop infusion formulation delivery
US8784369 *19 Jan 201122 Jul 2014Medtronic Minimed, Inc.System and method for providing closed loop infusion formulation delivery
US878437015 Dec 201122 Jul 2014Medtronic Minimed, Inc.Safety limits for closed-loop infusion pump control
US878800611 Dec 200922 Jul 2014Dexcom, Inc.System and methods for processing analyte sensor data
US87880078 Mar 201222 Jul 2014Dexcom, Inc.Transcutaneous analyte sensor
US878800831 May 201122 Jul 2014Dexcom, Inc.System and methods for processing analyte sensor data
US879026014 Oct 200929 Jul 2014Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US879295319 Mar 201029 Jul 2014Dexcom, Inc.Transcutaneous analyte sensor
US879295419 Mar 201029 Jul 2014Dexcom, Inc.Transcutaneous analyte sensor
US87929559 Jun 201129 Jul 2014Dexcom, Inc.Transcutaneous analyte sensor
US879517714 Jan 20095 Aug 2014Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8795224 *19 Jan 20115 Aug 2014Medtronic Minimed, Inc.System and method for providing closed loop infusion formulation delivery
US880161024 Jul 200912 Aug 2014Dexcom, Inc.Signal processing for continuous analyte sensor
US880161122 Mar 201012 Aug 2014Dexcom, Inc.Transcutaneous analyte sensor
US880161227 Apr 201212 Aug 2014Dexcom, Inc.System and methods for processing analyte sensor data
US880818227 Apr 201219 Aug 2014Dexcom, Inc.System and methods for processing analyte sensor data
US88082285 Jun 200819 Aug 2014Dexcom, Inc.Integrated medicament delivery device for use with continuous analyte sensor
US881207217 Apr 200819 Aug 2014Dexcom, Inc.Transcutaneous medical device with variable stiffness
US88120731 Jun 201019 Aug 2014Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US88214009 Feb 20112 Sep 2014Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US882512714 May 20102 Sep 2014Dexcom, Inc.Transcutaneous analyte sensor
US884055326 Feb 200923 Sep 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US88431871 Jun 201023 Sep 2014Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US884553611 Apr 200730 Sep 2014Dexcom, Inc.Transcutaneous analyte sensor
US885843410 Mar 200514 Oct 2014Dexcom, Inc.Transcutaneous analyte sensor
US888013718 Apr 20034 Nov 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US888274130 Apr 201211 Nov 2014Dexcom, Inc.Integrated delivery device for continuous glucose sensor
US888627222 Feb 200611 Nov 2014Dexcom, Inc.Analyte sensor
US88862737 Nov 200811 Nov 2014Dexcom, Inc.Analyte sensor
US891136915 Dec 200816 Dec 2014Dexcom, Inc.Dual electrode system for a continuous analyte sensor
US89158493 Feb 200923 Dec 2014Dexcom, Inc.Transcutaneous analyte sensor
US891585028 Mar 201423 Dec 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US891589328 Dec 201123 Dec 2014Palyon Medical (Bvi) LimitedVariable flow infusion pump system
US892031928 Dec 201230 Dec 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US892040130 Apr 201230 Dec 2014Dexcom, Inc.Integrated delivery device for continuous glucose sensor
US892658530 Mar 20126 Jan 2015Dexcom, Inc.Integrated delivery device for continuous glucose sensor
US892996819 Jul 20106 Jan 2015Dexcom, Inc.Dual electrode system for a continuous analyte sensor
US895629122 Feb 200617 Feb 2015Admetsys CorporationBalanced physiological monitoring and treatment system
US8956321 *26 Feb 201017 Feb 2015Ideal Medical Technologies Inc.Computerized system for blood chemistry monitoring
US896146616 Oct 201324 Feb 2015Palyon Medical (Bvi) LimitedProgrammable implantable pump design
US89743861 Nov 200510 Mar 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US898620913 Jul 201224 Mar 2015Dexcom, Inc.Transcutaneous analyte sensor
US901133129 Dec 200421 Apr 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US901133230 Oct 200721 Apr 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US90147737 Mar 200721 Apr 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US902057210 Sep 201028 Apr 2015Dexcom, Inc.Systems and methods for processing, transmitting and displaying sensor data
US90429532 Mar 200726 May 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US904419910 Mar 20052 Jun 2015Dexcom, Inc.Transcutaneous analyte sensor
US905041330 Apr 20129 Jun 2015Dexcom, Inc.Integrated delivery device for continuous glucose sensor
US905590114 Sep 201216 Jun 2015Dexcom, Inc.Transcutaneous analyte sensor
US906074219 Mar 201023 Jun 2015Dexcom, Inc.Transcutaneous analyte sensor
US90666943 Apr 200730 Jun 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US906669512 Apr 200730 Jun 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US906669727 Oct 201130 Jun 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US907247721 Jun 20077 Jul 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US907860717 Jun 201314 Jul 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US907860813 Jul 201214 Jul 2015Dexcom, Inc.System and methods for processing analyte sensor data for sensor calibration
US907862631 Mar 201114 Jul 2015Dexcom, Inc.Transcutaneous analyte sensor
US910762315 Apr 200918 Aug 2015Dexcom, Inc.Signal processing for continuous analyte sensor
US913540224 Oct 200815 Sep 2015Dexcom, Inc.Systems and methods for processing sensor data
US914356920 Feb 200922 Sep 2015Dexcom, Inc.Systems and methods for processing, transmitting and displaying sensor data
US91492199 Feb 20116 Oct 2015Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US914923313 Jun 20126 Oct 2015Dexcom, Inc.Systems and methods for processing sensor data
US914923413 Jun 20126 Oct 2015Dexcom, Inc.Systems and methods for processing sensor data
US915549618 Feb 201113 Oct 2015Dexcom, Inc.Low oxygen in vivo analyte sensor
US915584326 Jul 201213 Oct 2015Dexcom, Inc.Integrated delivery device for continuous glucose sensor
US919232823 Sep 200924 Nov 2015Dexcom, Inc.Signal processing for continuous analyte sensor
US92204499 Jul 201329 Dec 2015Dexcom, Inc.System and methods for processing analyte sensor data for sensor calibration
US924203929 Sep 201026 Jan 2016Admetsys CorporationSystem and method for differentiating containers in medication delivery
US92479004 Jun 20132 Feb 2016Dexcom, Inc.Analyte sensor
US92479012 Aug 20062 Feb 2016Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US927214031 Mar 20081 Mar 2016Medtronic, Inc.Method, system and device for treating disorders of the pelvic floor by electrical stimulation of the sacral and/or pudendal nerves
US928292525 Mar 201015 Mar 2016Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US93141967 Sep 201219 Apr 2016Dexcom, Inc.System and methods for processing analyte sensor data for sensor calibration
US932671429 Jun 20103 May 2016Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US93267165 Dec 20143 May 2016Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US932837116 Jul 20133 May 2016Dexcom, Inc.Sensor head for use with implantable devices
US933922231 May 201317 May 2016Dexcom, Inc.Particle-containing membrane and particulate electrode for analyte sensors
US933923816 May 201217 May 2016Dexcom, Inc.Systems and methods for processing sensor data
US935166812 Oct 200931 May 2016Dexcom, Inc.Signal processing for continuous analyte sensor
US936417323 Sep 200914 Jun 2016Dexcom, Inc.Signal processing for continuous analyte sensor
US941477710 Mar 200516 Aug 2016Dexcom, Inc.Transcutaneous analyte sensor
US94209651 Jul 201123 Aug 2016Dexcom, Inc.Signal processing for continuous analyte sensor
US94209684 Apr 201223 Aug 2016Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US942133214 Jan 201523 Aug 2016Admetsys CorporationBalanced physiological monitoring and treatment system
US942718312 Jul 201130 Aug 2016Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US944619426 Mar 201020 Sep 2016Dexcom, Inc.Methods and systems for promoting glucose management
US945190819 Dec 201227 Sep 2016Dexcom, Inc.Analyte sensor
US945191027 Aug 201027 Sep 2016Dexcom, Inc.Transcutaneous analyte sensor
US94522589 Oct 200727 Sep 2016Dexcom, Inc.Integrated insulin delivery system with continuous glucose sensor
US945225925 Oct 201327 Sep 2016Dexcom, Inc.Integrated insulin delivery system with continuous glucose sensor
US945714630 Dec 20134 Oct 2016Dexcom, Inc.Integrated insulin delivery system with continuous glucose sensor
US946327730 Dec 201311 Oct 2016Dexcom, Inc.Integrated insulin delivery system with continuous glucose sensor
US9480796 *24 Jun 20141 Nov 2016Medtronic Minimed, Inc.System and method for providing closed loop infusion formulation delivery
US949815516 Oct 200822 Nov 2016Dexcom, Inc.Signal processing for continuous analyte sensor
US949815930 Oct 200722 Nov 2016Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US950441315 Apr 201329 Nov 2016Dexcom, Inc.Dual electrode system for a continuous analyte sensor
US95107824 Apr 20126 Dec 2016Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US953894625 Mar 201010 Jan 2017Dexcom, Inc.Integrated receiver for continuous analyte sensor
US957293525 Oct 201321 Feb 2017Dexcom, Inc.Integrated insulin delivery system with continuous glucose sensor
US957293625 Oct 201321 Feb 2017Dexcom, Inc.Integrated insulin delivery system with continuous glucose sensor
US957905326 Mar 201028 Feb 2017Dexcom, Inc.Dual electrode system for a continuous analyte sensor
US95856074 Apr 20127 Mar 2017Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US958600425 Oct 20137 Mar 2017Dexcom, Inc.Integrated insulin delivery system with continuous glucose sensor
US959745325 Oct 201321 Mar 2017Dexcom, Inc.Integrated insulin delivery system with continuous glucose sensor
US961003113 Apr 20114 Apr 2017Dexcom, Inc.Transcutaneous analyte sensor
US96100349 Nov 20154 Apr 2017Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US964906929 Jun 201616 May 2017Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US96560209 Jun 201023 May 2017Imperial Innovations LimitedGlucagon pump controller
US966867726 Oct 20156 Jun 2017Dexcom, Inc.Analyte sensor
US966868218 Dec 20146 Jun 2017Dexcom, Inc.Transcutaneous analyte sensor
US971744915 Jan 20131 Aug 2017Dexcom, Inc.Systems and methods for processing sensor data
US971786516 Dec 20151 Aug 2017Admetsys CorporationSystem and method for differentiating containers in medication delivery
US972402824 Nov 20148 Aug 2017Dexcom, Inc.Analyte sensor
US97240456 Apr 20178 Aug 2017Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US97411399 Aug 201322 Aug 2017Dexcom, Inc.Integrated medicament delivery device for use with continuous analyte sensor
US975044115 Aug 20165 Sep 2017Dexcom, Inc.Signal processing for continuous analyte sensor
US975046014 Apr 20175 Sep 2017Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US97570611 Sep 201512 Sep 2017Dexcom, Inc.Low oxygen in vivo analyte sensor
US20020114739 *24 Dec 200122 Aug 2002Weigl Bernard H.Microfluidic cartridge with integrated electronics
US20030125662 *3 Jan 20023 Jul 2003Tuan BuiMethod and apparatus for providing medical treatment therapy based on calculated demand
US20030171711 *6 Mar 200211 Sep 2003Rohr William L.Closed-loop drug delivery system
US20040143242 *22 Jan 200322 Jul 2004Lev LudinTroubleshooting accelerator system for implantable drug delivery pumps
US20040158232 *7 Aug 200312 Aug 2004Schetky Laurence MacdonaldImplantable artificial pancreas
US20040220517 *20 May 20044 Nov 2004Medtronic Minimed, Inc.System and method for providing closed loop infusion formulation delivery
US20040220518 *23 Dec 20034 Nov 2004Medtronic, Inc.Drug solution density adjustment systems and methods
US20040220543 *23 Dec 20034 Nov 2004Medtronic, Inc.Trailing system for evaluation of the efficacy of the treatment
US20040220544 *23 Dec 20034 Nov 2004Medtronic, Inc.Method of delivering drug to brain via spinal cord
US20040220545 *23 Dec 20034 Nov 2004Medtronic, Inc.Method of delivering drugs to specific regions of the spinal cord
US20040220546 *23 Dec 20034 Nov 2004Medtronic, Inc.Reduction of inflammatory mass with spinal catheters
US20040220547 *23 Dec 20034 Nov 2004Medtronic, IncMultiple infusion section catheters, systems, and methods
US20040220552 *23 Dec 20034 Nov 2004Medtronic, Inc.Implantable drug delivery systems and methods
US20040267100 *20 May 200230 Dec 2004Mark FaupelSystem and method for monitoring or treating a health condition
US20050015117 *30 Apr 200420 Jan 2005Medtronic, Inc.Method, system and device for treating disorders of the pelvic floor by electrical stimulation of and the delivery of drugs to the left and right pudendal nerves
US20050021008 *30 Apr 200427 Jan 2005Medtronic, Inc.Method, system and device for treating disorders of the pelvic floor by drug delivery to the pudendal and sacral nerves
US20050113877 *26 Nov 200326 May 2005Medtronic, Inc.Method, system and device for treating disorders of the pelvic floor by means of electrical stimulation of the pudenal and associated nerves, and the optional delivery of drugs in association therewith
US20050123442 *4 Dec 20039 Jun 2005Yuandong GuAnalyte detector
US20050137577 *22 Jun 200423 Jun 2005Heruth Kenneth T.Catheters with tracking elements and permeable membranes
US20050137578 *22 Jun 200423 Jun 2005Medtronic, Inc.Catheters incorporating valves and permeable membranes
US20050229683 *31 May 200520 Oct 2005Codman & Shurtleff, Inc.Trouble shooting accelerator system for implantable drug delivery pumps
US20060036286 *7 Oct 200516 Feb 2006Whitehurst Todd KMonitoring, preventing, and treating rejection of transplanted organs
US20060122659 *30 Apr 20048 Jun 2006Medtronic, Inc.Method, system and device for treating disorders of the pelvic floor by electrical stimulation of and the delivery of drugs to the left and right pudendal nerves
US20060160722 *23 Dec 200320 Jul 2006Green Daniel TCompositions and methods for the prevention and control of insulin-induced hypoglycemia
US20060253105 *28 Jun 20069 Nov 2006Codman & Shurtleff, Inc.Troubleshooting accelerator system for implantable drug delivery pumps
US20060259015 *10 May 200516 Nov 2006Palion Medical CorporationImplantable pump with infinitely variable resistor
US20060259016 *10 May 200516 Nov 2006Palion Medical CorporationReduced size implantable pump
US20060264895 *18 May 200523 Nov 2006Flanders Samuel JSystem for managing glucose levels in patients with diabetes or hyperglycemia
US20070088271 *10 Oct 200619 Apr 2007Richards Cynthia CMedication device
US20070249007 *20 Apr 200725 Oct 2007Rosero Spencer ZMethod and apparatus for the management of diabetes
US20070254004 *29 Nov 20061 Nov 2007Rosero Spencer ZSystem and method for supporting a biological chip device
US20070255333 *28 Apr 20061 Nov 2007Medtronic, Inc.Neuromodulation therapy for perineal or dorsal branch of pudendal nerve
US20080071209 *29 Mar 200720 Mar 2008Maas Medical, LlcMethod and system for controlled infusion of therapeutic substances
US20080071210 *29 Mar 200720 Mar 2008Maas Medical, LlcMethod and system for controlled infusion of therapeutic substances
US20080071217 *29 Mar 200720 Mar 2008Maas Medical, LlcMethod and system for controlled infusion of therapeutic substances
US20080071251 *29 Mar 200720 Mar 2008Maas Medical, LlcMethod and system for controlled infusion of therapeutic substances
US20080096801 *21 Dec 200724 Apr 2008Diobex, Inc.Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US20080125759 *1 Feb 200829 May 2008Codman & Shurtleff, Inc.Convection-enhanced drug delivery device and method of use
US20080160071 *29 Oct 20073 Jul 2008Diobix, Inc.Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US20080160072 *29 Oct 20073 Jul 2008Diobex, Inc.Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US20080160073 *29 Oct 20073 Jul 2008Diobex, Inc.Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US20080166399 *29 Oct 200710 Jul 2008Diobex, Inc.Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US20080183236 *31 Mar 200831 Jul 2008Medtronic, Inc.Method, system and device for treating disorders of the pelvic floor by electrical stimulation of the sacral and/or pudendal nerves
US20080194924 *22 Feb 200614 Aug 2008Admetsys CorporationBalanced Physiological Monitoring and Treatment System
US20080214919 *12 Dec 20074 Sep 2008Lifescan, Inc.System and method for implementation of glycemic control protocols
US20080277065 *8 May 200713 Nov 2008Brett MoodyHand-Held Labeling Apparatus Having Accessory Storage
US20090099438 *17 Dec 200816 Apr 2009Flanders Samuel JSystem for managing glucose levels in patients with diabetes or hyperglycemia
US20090099507 *26 Oct 200616 Apr 2009VariakDevice for Automatic Regulation of the Concentration of Glucose in the Blood of a Diabetes Patient
US20090264856 *23 Jun 200922 Oct 2009Medronic MiniMed, Inc.Safety limits for closed-loop infusion pump control
US20100069892 *19 Nov 200918 Mar 2010Palyon Medical (Bvi) LimitedVariable flow infusion pump system
US20100179130 *3 Jul 200815 Jul 2010SYNGIS Bioscience GmbH & Co. KGUse of piperine and derivatives thereof for the therapy of neurological conditions
US20100217238 *26 Feb 201026 Aug 2010Dejournett LeonComputerized System for Blood Chemistry Monitoring
US20110054391 *3 Jun 20103 Mar 2011Ward W KennethAnalyte sensing and response system
US20110112505 *19 Jan 201112 May 2011Medtronic Minimed, Inc.System and method for providing closed loop infusion formulation delivery
US20110112506 *19 Jan 201112 May 2011Medtronic Minimed, Inc.System and method for providing closed loop infusion formulation delivery
US20110137208 *23 Jul 20099 Jun 2011Admetsys CorporationDevice and method for automatically sampling and measuring blood analytes
US20110184380 *19 Jan 201128 Jul 2011Medtronic Minimed, Inc.System and method for providing closed loop infusion formulation delivery
US20130274653 *15 Mar 201317 Oct 2013Bonutti Research, Inc.Patient Monitoring Apparatus and Method for Orthosis and Other Devices
US20150018757 *24 Jun 201415 Jan 2015Medtronic Minimed, Inc.System and method for providing closed loop infusion formulation delivery
US20160106363 *16 Oct 201521 Apr 2016Exerscrip, LLCAlgorithms for Diabetes Exercise Therapy
US20160310668 *7 Jul 201627 Oct 2016Indiana University Health, Inc.System for managing glucose levels in patients with diabetes or hyperglycemia
USRE4339913 Jun 200822 May 2012Dexcom, Inc.Electrode systems for electrochemical sensors
USRE446951 May 20127 Jan 2014Dexcom, Inc.Dual electrode system for a continuous analyte sensor
CN104027867A *13 Jun 201410 Sep 2014杨力Portable intelligent dual-function diabetes treatment pump
DE10011284A1 *8 Mar 200020 Sep 2001Disetronic Licensing AgDevice for in vivo analysis of body fluid, useful especially for monitoring glucose levels, comprises implanted light emitter and external detector
DE10011284B4 *8 Mar 200028 Jun 2007Disetronic Licensing AgVorrichtung für eine In-vivo Messung der Konzentration eines Inhaltsstoffs einer Körperflüssigkeit
DE19621770C1 *30 May 19962 Jan 1998Siemens AgImplantierbare Insulinpumpe
EP0793978A2 *4 Mar 199710 Sep 1997BIOTRONIK Mess- und Therapiegeräte GmbH & Co Ingenieurbüro BerlinTherapy device
EP0793978A3 *4 Mar 199721 Apr 1999BIOTRONIK Mess- und Therapiegeräte GmbH & Co Ingenieurbüro BerlinTherapy device
EP0958780A1 *7 May 199924 Nov 1999Disetronic Licensing AGSensor system with permanently implanted access
EP2186525A231 Dec 200319 May 2010SYGNIS Bioscience GmbH & Co KGG-CSF for use in the treatment of Parkinson's disease
EP2251010A18 May 200917 Nov 2010Sygnis Bioscience GmbH & Co. KGUse of thiabendazole and derivatives thereof for the therapy of neurological conditions
EP2295069A129 Dec 200416 Mar 2011Sygnis Bioscience GmbH & Co. KGTreatment of neurological disorders with haematopoietic growth factors
EP2311483A131 Dec 200320 Apr 2011SYGNIS Bioscience GmbH & Co KGGCSF for use in treating a neurological disease with pathophysiological mechanisms involving ischemia or hypoxia
WO1997001986A1 *8 Jul 199623 Jan 1997Thomas Jefferson UniversityImplantable sensor and system for measurement and control of blood constituent levels
WO1998001071A1 *8 Jul 199715 Jan 1998Animas CorporationImplantable sensor and system for in vivo measurement and control of fluid constituent levels
WO1998031276A1 *16 Jan 199823 Jul 1998Palti Yoram ProfSensor utilizing living muscle cells
WO2002027294A2 *1 Oct 20014 Apr 2002Michele DelsanterMultifunctional and multiparametric biochip arrangement
WO2002027294A3 *1 Oct 20015 Dec 2002Michele DelsanterMultifunctional and multiparametric biochip arrangement
WO2002078532A1 *2 Apr 200210 Oct 2002Diametrics Medical LimitedImplantable sensor
WO2003023708A2 *4 Sep 200220 Mar 2003Medtronic Minimed, Inc.A system and method for providing closed loop infusion formulation delivery
WO2003023708A3 *4 Sep 200225 Sep 2003Medtronic Minimed IncA system and method for providing closed loop infusion formulation delivery
WO2007047279A1 *10 Oct 200626 Apr 2007Richards Cynthia CDispenser having a first pump for insulin and a second pump for glucose or glucagon
WO2007049961A2 *26 Oct 20063 May 2007Inreda Diabetic B.V.Device for automatic regulation of the concentration of glucose in the blood of a diabetes patient
WO2007049961A3 *26 Oct 200612 Jul 2007Robin KoopsDevice for automatic regulation of the concentration of glucose in the blood of a diabetes patient
WO2009032553A222 Aug 200812 Mar 2009Leon DejournettCatheter and computerized system for intravenous blood chemistry monitoring
WO2009032553A3 *22 Aug 200826 Nov 2009Leon DejournettCatheter and computerized system for intravenous blood chemistry monitoring
WO2009048462A1 *9 Oct 200716 Apr 2009Dexcom, Inc.Integrated insulin delivery system with continuous glucose sensor
Classifications
U.S. Classification604/67
International ClassificationA61M5/142, A61M5/172
Cooperative ClassificationA61M5/1723, A61M5/14276
European ClassificationA61M5/172B
Legal Events
DateCodeEventDescription
27 Jun 1994ASAssignment
Owner name: CB-CARMEL BIOTECHNOLOGY LTD., ISRAEL
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PALTI, YORAM;REEL/FRAME:007056/0330
Effective date: 19940624
1 Jun 1999FPAYFee payment
Year of fee payment: 4
20 Sep 1999ASAssignment
Owner name: MEDTRONIC INTERNATIONAL TECHNOLOGY, INC., MINNESOT
Free format text: SECURITY INTEREST;ASSIGNOR:CARMEL BIOSENSORS LTD.;REEL/FRAME:010238/0971
Effective date: 19990903
20 May 2003FPAYFee payment
Year of fee payment: 8
17 May 2007FPAYFee payment
Year of fee payment: 12